Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation

Major ABO mismatching is not considered a contraindication to allogeneic haematopoietic stem cell transplantation (HSCT). Modern reduced-intensity conditioning and reduced-toxicity regimens cause much less myeloablation than conventional myeloablative regimens, such as cyclophosphamide with busulfan...

詳細記述

保存先:
書誌詳細
主要な著者: Aung, Fleur M., Lichtiger, Benjamin, Bassett, Roland, Liu, Ping, Alousi, Amin, Bashier, Qaiser, Ciurea, Stefan O., de Lima, Marcos J., Hosing, Chitra, Kebriaei, Partow, Nieto, Yago, Oran, Betul, Parmar, Simrit, Qazilbash, Muzaffar, Shah, Nina, Khouri, Issa, Champlin, Richard E., Popat, Uday
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4078723/
https://ncbi.nlm.nih.gov/pubmed/23330820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12210
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料